Off-patent Drugs Bill — Second Reading — 7 Nov 2014 at 12:28
The majority of MPs voted for the licensing of off-patent drugs in relation to new ways which have been found to use them.
MPs were considering the Off-patent Drugs Bill.
The Bill requires the Secretary of State to take steps to secure a licence for off-patent drugs in relation to new ways which have been found to use them. The Bill also requires an annual report on the steps taken under its provisions.
The motion supported by the majority of MPs taking part in the vote was:
- That the Bill be now read a Second time.
Support for this motion means the Bill continues on its path towards becoming law.
While moving the motion Jonathan Evans MP explained his motivation for introducing the Bill saying there was no incentive for pharmaceutical companies, or anyone else, to apply for licences for new uses of off-patent drugs as they don't have a monopoly on making money from that drug. He stated that clinicians were deterred from prescribing drugs in circumstances for which they are not licensed and noted it is illegal to advertise and sell such drugs for such purposes if the drug is not licensed.
-  Parliament's webpage on the Off-patent Drugs Bill
-  Jonathan Evans MP, (Cardiff North, Conservative), House of Commons, 7 November 2014
MPs for which their vote in this division differed from the majority vote of their party are marked in red. Also shows which MPs were ministers at the time of this vote. You can also see every eligible MP including those who did not vote in this division.